课题基金 / 基金详情

MYOCARDIAL SUBSTRATE SELECTION AND SWITCHING IN LEAN AND OBESE HUMANS

MYOCARDIAL SUBSTRATE SELECTION AND SWITCHING IN LEAN AND OBESE HUMANS
瘦人和肥胖人的心肌基质选择和转换
批准号:
7717514
负责人:
Kieren J Mather
金额:
$0.09万
依托单位国家:
美国
项目类别:
财政年份:
2007
资助国家:
美国
项目状态:
已结题
起止时间:
2007-12-01 至 2008-05-31

项目摘要

项目成果

Kieren J Mather的其他基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. The myocardium has the capacity to switch between free fatty acids and glucose as oxidative substrates, in response to changes in substrate supply, work demand, and local and systemic regulators. Disorders of metabolism, such as obesity and diabetes, are associated with increased rates of myocardial dysfunction, and it is possible that alterations in fuel selection underlie this relationship. Comparatively little is known about myocardial fuel selection in the basal state and in response to insulin in these disease states. The current proposal will test the hypothesis that the contribution of fatty acids to overall myocardial metabolism is increased in obese insulin resistant subjects, and that the capacity to switch to glucose metabolism under insulin stimulation is reduced. In the current protocol, we will perform positron emission tomography measurements of myocardial fatty acid oxidation, total oxidation, and tissue perfusion in lean and obese subjects. These studies will be performed under basal fasting conditions, and under steady state conditions of hyperinsulinemia. The resulting data will be used to support a future grant proposal which will explore these questions in more detail.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Cardiovascular effects of GLP-1 in obesity/metabolic syndrome
Cardiovascular effects of GLP-1 in obesity/metabolic syndrome
Cardiovascular effects of GLP-1 in obesity/metabolic syndrome
Preservation of Beta Cell Function in Prediabetes Early Type 2 Diabetes